Bacteremia Due toKlebsiella pneumoniaeIsolates Producing the TEM‐52 Extended‐Spectrum β‐Lactamase: Treatment Outcome of Patients Receiving Imipenem or Ciprofloxacin

This publication has 31 references indexed in Scilit:

• Extended Spectrum ??-Lactamase (ESBL)-Producing Enterobacteriaceae
  Drugs, 2003
• Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia
  Journal of Hospital Infection, 2002
• Bloodstream Infections by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome
  Antimicrobial Agents and Chemotherapy, 2002
• Extended-Spectrum β-Lactamases: Frequency, Risk Factors, and Outcomes
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Characterization of an Outbreak Due to Extended‐Spectrum β‐Lactamase–ProducingKlebsiella pneumoniaein a Pediatric Intensive Care Unit Transplant Population
  Clinical Infectious Diseases, 2000
• Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)
  Clinical Microbiology & Infection, 2000
• PATHOGENS RESISTANT TO ANTIMICROBIAL AGENTS: Epidemiology, Molecular Mechanisms, and Clinical Management
  Infectious Disease Clinics of North America, 2000
• Outbreak of a Multiresistant Klebsiella pneumoniae Strain in an Intensive Care Unit: Antibiotic Use as Risk Factor for Colonization and Infection
  Clinical Infectious Diseases, 2000
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995